Veradermics Prices Upsized IPO at $16 Per Share to Raise Approximately $92 Million

Veradermics has announced the pricing of its upsized initial public offering (IPO). The company is offering 5,750,000 shares of its common stock at a price of $16.00 per share. This represents an increase from the originally planned offering size. Veradermics expects to raise approximately $92 million before deducting underwriting discounts, commissions, and other expenses related to the offering.

The shares are set to begin trading on February 4, 2026, on the Nasdaq Global Market under the ticker symbol “MANE.” The IPO is expected to close on February 8, 2026, subject to customary closing conditions. In addition to the initial offering, underwriters have been granted a 30-day option to purchase up to an additional 862,500 shares at the IPO price. The proceeds from this offering will be used for general corporate purposes and potential strategic initiatives.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

Author

GOAI